Skip to content
Recall Observatory FDA recall evidence

Drug product

CLENZIderm M.D. Acne Therapeutic System Normal to Oily Skin kit, Distributed by OMP, Inc., Long Beach, CA 90806, Kit is comprised of: Daily Care Foaming Cleanser (Salicylic Acid 2%) NDC 62032-111; Pore Therapy (Salicylic Acid 2%) NDC 62032-110 and Therapeutic Lotion (Benzoyl Peroxide 5%) NDC 562032-113). Product under recall is the Pore Therapy (Salicylic Acid 2%), NDC 62032-110.

D-916-2013

May 01, 2013

Class II

Product summary

Firm
Medicis Pharmaceutical Corp
Event
Event 65559
Status
Terminated
Classification
Class II
Quantity
2491 Kits; Expanded 8/29/2013 to include an additional 907 units.
Official record key
drug-enforcement:D-916-2013

Official wording

Reason: cGMP Deviations; during the production process, CLENZIderm M.D. Daily Foam Cleanser was filled into some bottles labeled as CLENZIderm M.D. Pore Therapy

Code information: Lot #11L1074, NDC 62032-110; Expanded 8/29/2013 to include Lot 11J1075, NDC 62032-511, Exp. 10/14.

Distribution pattern: Nationwide, Great Britain, Mexico, Russia and The Ukraine.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP Deviations